EC - Horizon Europe logo

DEVELOPMENT OF IMMUNE TOLERANCE THERAPIES FOR THE TREATMENT OF RHEUMATIC DISEASES
Date de clôture : 10 janv. 2017  
APPEL À PROJET CLÔTURÉ

EU logo mono EC - Horizon Europe

Commentaires Suivre

 Soins de santé
 Médicaments
 Équipement médical
 Biotechnologie médicale
 Horizon Europe
 Recherche

Topic Description
Specific Challenge:

Autoimmune diseases affect approximately 5% of the population of Europe, with two-thirds of the patients being female.

Scope:

Development of a translational research project for the induction and monitoring of immune tolerance in Rheumatic Diseases: Rheumatoid Arthritis (RA).

Expected Impact:

If successful, immune tolerance approaches would revolutionize treatment of RA by inducing drug-free remission. Coupled with diagnostic tests, screening initiatives for “at-risk” individuals, it may stop the disease before joint damage can occur. For healthy but at-risk patient, this would offer a screening and “vaccination” for the prevention of RA.



Lien officiel :   Disponible pour les utilisateurs enregistrés